Pediatric heart transplantation after declaration of cardiocirculatory death

Mark M Boucek1, Christine Mashburn, Susan M Dunn

  • 1Department of Pediatrics, Joe DiMaggio Children's Hospital, Hollywood, FL 33021, USA. mboucek@mhs.net

Insights

Infants undergoing heart transplants using organs from donors who died from cardiocirculatory causes showed excellent survival and outcomes. This approach may reduce critical waiting list mortality in pediatric cardiac transplantation.

Area of Science:

  • Cardiology
  • Transplantation immunology
  • Pediatric surgery

Background:

  • Infant heart transplantation is critical due to high waiting list mortality.
  • Standard organ donation protocols may not adequately address the pediatric donor pool.
  • Cardiocirculatory death donors present a potential resource for infant cardiac transplantation.

Purpose of the Study:

  • To evaluate the feasibility and outcomes of using organs from cardiocirculatory death donors for infant orthotopic cardiac transplantation.
  • To compare survival and immunological outcomes with standard organ donation in infants.

Main Methods:

  • Retrospective analysis of three infants receiving heart transplants from cardiocirculatory death donors.
  • Comparison with a control group of 17 infants receiving standard donor organs.
  • Assessment of 6-month and long-term survival, rejection episodes, and echocardiographic function.

Main Results:

  • Successful transplantation in all three high-risk infants.
  • 100% 6-month survival compared to 84% in controls.
  • Similar low rates of rejection episodes and comparable echocardiographic function at 6 months.
  • No late deaths or significant immunological differences observed up to 3.5 years.

Conclusions:

  • Organs from cardiocirculatory death donors are viable for infant orthotopic cardiac transplantation.
  • This strategy offers a promising avenue to decrease mortality in infants awaiting heart transplants.
  • Outcomes are comparable to standard donor organs, suggesting safety and efficacy.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...